lexiara

(i)

CRR3

a non-IPRE exposure shall be treated in accordance with Article 125(1):

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-09-25 · Text as adopted (Official Journal); later amendments are not incorporated in this text.